GITNUXREPORT 2026

Scabies Statistics

Scabies is a common but preventable global skin infestation causing intense itching.

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

Intense pruritus, worse at night, affects 80-90% of scabies patients due to hypersensitivity.

Statistic 2

Burrows appear as linear, thread-like, grayish-white tracks 2-15 mm long on the skin.

Statistic 3

Papular lesions and excoriations are common on flexor wrists, elbows, axillae, and waistline.

Statistic 4

In infants, scabies presents with vesicles, pustules, and involvement of palms and soles in 60% of cases.

Statistic 5

Nodular scabies causes persistent, pruritic, reddish-brown nodules up to 1 cm on genitalia.

Statistic 6

Secondary bacterial infections like impetigo occur in 40-50% of untreated scabies cases.

Statistic 7

Crusted scabies features hyperkeratotic plaques with widespread erythroderma and nail dystrophy.

Statistic 8

Post-scabietic itch persists for 2-4 weeks after successful treatment in 30-50% of patients.

Statistic 9

Norwegian scabies affects 5-10% of AIDS patients, with thick crusts harboring millions of mites.

Statistic 10

Pruritus intensity correlates with mite density and host sensitization, peaking 3-4 weeks post-infestation.

Statistic 11

Burrows are serpiginous, 1-10 mm long, with a terminal vesicle.

Statistic 12

Webbed fingers show involvement in 90% of adult cases.

Statistic 13

Genital nodules persist months post-cure due to persistent antigenicity.

Statistic 14

In elderly, lesions mimic eczema with generalized dryness and scaling.

Statistic 15

Bullous scabies presents with tense blisters histologically identical to bullous pemphigoid.

Statistic 16

Average incubation period is 4-6 weeks in first infestation, 1-4 days on reinfestation.

Statistic 17

Secondary S. aureus bacteremia complicates 1-2% of severe crusted cases.

Statistic 18

Waistline umbilicus involvement classic in 70% adults.

Statistic 19

Face/neck spared in adults but affected in 50% infants.

Statistic 20

Pyoderma from scratching leads to MRSA colonization in 20%.

Statistic 21

Urticarial reactions precede papules in sensitized patients.

Statistic 22

Thumb web space burrows diagnostic in 85% cases.

Statistic 23

Alopecia and nail invasion in crusted variant.

Statistic 24

Definitive diagnosis requires microscopic identification of mites, eggs, or scybala from skin scrapings.

Statistic 25

Dermoscopy reveals the delta-wing sign (jet with contrail) in 80% of active burrows.

Statistic 26

Adhesive tape test improves mite detection yield by 50% compared to standard scrapings.

Statistic 27

PCR assays detect scabies DNA with 94% sensitivity in crusted cases versus 46% for microscopy.

Statistic 28

Clinical diagnosis accuracy is 70-90% based on pruritus, burrows, and distribution in naive patients.

Statistic 29

Videodermatoscopy visualizes mite movement in real-time, confirming infestation noninvasively.

Statistic 30

Burrow ink test uses marker pen to highlight linear burrows under alcohol wipe.

Statistic 31

ELISA serology for scabies antigens shows promise but lacks specificity at 75%.

Statistic 32

Confocal microscopy detects mites at 100% sensitivity in positive scrapings.

Statistic 33

Acetone-based ink burrow test enhances visibility in light-skinned patients.

Statistic 34

Hypersalivation test (burrow scraping after provocation) yields mites in 70% cases.

Statistic 35

Optical coherence tomography visualizes burrow depth at 0.5-1 mm subsurface.

Statistic 36

Nested PCR targets cytochrome c oxidase gene with 98% specificity.

Statistic 37

Clinical tetrad (pruritus, burrows, contact history, typical sites) confirms 85% cases.

Statistic 38

Potassium hydroxide 10-20% aids scraping without obscuring mites.

Statistic 39

Smartphone dermoscopy apps detect burrows with 90% accuracy.

Statistic 40

IgE levels elevated 10-fold in chronic scabies.

Statistic 41

Ultrasound shows hypoechoic burrow tracts in dermis.

Statistic 42

Tzanck prep rarely shows mites but eosinophils plentiful.

Statistic 43

Multiplex PCR distinguishes human from animal scabies.

Statistic 44

Scabies affects an estimated 200 million people worldwide annually, with higher prevalence in tropical regions.

Statistic 45

In the United States, approximately 1% of the population experiences scabies each year, equating to over 3 million cases.

Statistic 46

Crusted scabies occurs in 0.2-0.4% of all scabies cases but is highly contagious, affecting immunosuppressed individuals disproportionately.

Statistic 47

Among Aboriginal communities in Australia, scabies prevalence reaches up to 50% in children under 5 years.

Statistic 48

Global incidence of scabies is approximately 100 million new cases per year, per WHO estimates.

Statistic 49

In overcrowded nursing homes, scabies outbreak rates can exceed 30% of residents within weeks.

Statistic 50

Scabies prevalence in developing countries averages 10-15% in school-aged children.

Statistic 51

During refugee crises, scabies incidence can surge to 20-40% among displaced populations.

Statistic 52

In Fiji, community-wide scabies prevalence was reduced from 32% to 2% after mass drug administration.

Statistic 53

HIV-positive individuals have a 10-fold higher risk of scabies infestation compared to the general population.

Statistic 54

In 2018, WHO added scabies to neglected tropical diseases, promoting integrated control strategies.

Statistic 55

Scabies prevalence in urban slums of India reaches 15-20% among children under 10.

Statistic 56

Institutional outbreaks report attack rates of 10-60% without intervention.

Statistic 57

Seasonal peaks in scabies occur in winter due to close indoor contact.

Statistic 58

Among homeless populations, scabies seroprevalence is 25-30%.

Statistic 59

Scabies contributes to 5-10% of dermatology consultations in tropical clinics.

Statistic 60

In Solomon Islands, scabies impetigo prevalence dropped 50% post-ivermectin MDA.

Statistic 61

Scabies prevalence in French Guiana prisons was 27% pre-intervention.

Statistic 62

Over 455 million people at risk globally, per 2017 modeling.

Statistic 63

Endemic scabies in Papua New Guinea affects 20-30% of children.

Statistic 64

Scabies outbreaks in schools report 5-15% class involvement.

Statistic 65

Incidence in daycare centers is 2-5 times higher than community rates.

Statistic 66

Global burden equates to 0.1% DALYs lost annually.

Statistic 67

Scabies is caused by the mite Sarcoptes scabiei var. hominis, a microscopic arachnid measuring 0.3-0.4 mm in length.

Statistic 68

Female scabies mites burrow into the stratum corneum at a rate of 2-3 mm per day to lay eggs.

Statistic 69

A single fertilized female mite can produce up to 3 eggs per day over her 4-5 week lifespan.

Statistic 70

Scabies mites survive off the human host for 24-36 hours at room temperature and humidity.

Statistic 71

In crusted scabies, mite burden can exceed 1 million per individual, compared to 10-15 in classic cases.

Statistic 72

Scabies mites have eight short legs and cutaneous striations visible under microscopy at 10-40x magnification.

Statistic 73

The mite's fecal pellets (scybala) contain antigens that trigger type I hypersensitivity reactions.

Statistic 74

Sarcoptes scabiei completes its entire lifecycle on the human host, from egg to adult in 10-17 days.

Statistic 75

Mites prefer warm, moist skin areas like interdigital spaces, wrists, and genitals for burrowing.

Statistic 76

Genetic variants of S. scabiei show host adaptation, with animal strains rarely infesting humans successfully.

Statistic 77

Female scabies mites are larger (0.4 mm) than males (0.2 mm) and dorsoventrally flattened.

Statistic 78

Eggs hatch in 3-4 days, releasing hexapod larvae that mature in 10-14 days.

Statistic 79

Mite saliva contains hyaluronidase facilitating skin penetration.

Statistic 80

Off-host survival drops to 2-3 days at low humidity (<40%).

Statistic 81

Human scabies strains differ genetically from canine strains by 3-4% in mitochondrial DNA.

Statistic 82

Mites feed on liquefied epidermal cells and serum within burrows.

Statistic 83

Sensitization occurs after 4 weeks, explaining asymptomatic initial infestation.

Statistic 84

Mite fecundity peaks at 33°C and 80% humidity.

Statistic 85

Larvae molt to nymphs in skin molting chambers over 3-4 days.

Statistic 86

Mites cause spongiosis and acanthosis histologically.

Statistic 87

Transmission requires 20-30 minutes skin-to-skin contact typically.

Statistic 88

Fomite transmission rare but possible via infested bedding.

Statistic 89

Mite genome sequenced reveals detoxification genes for host defenses.

Statistic 90

First-line treatment is topical 5% permethrin cream, applied head-to-toe for 8-14 hours.

Statistic 91

Oral ivermectin 200 mcg/kg single dose cures 95% of uncomplicated scabies cases.

Statistic 92

For crusted scabies, combine ivermectin (2 doses 7-14 days apart) with keratolytics.

Statistic 93

Bedding and clothing require hot washing (>50°C) or sealing for 3 days to kill mites.

Statistic 94

Mass drug administration with ivermectin reduced scabies prevalence by 85% in Pacific islands.

Statistic 95

Treat all household contacts simultaneously regardless of symptoms to prevent reinfestation.

Statistic 96

Benzyl benzoate 25% lotion requires 24-hour application but has higher irritation rates.

Statistic 97

Pruritus relief with oral antihistamines or topical crotamiton aids compliance post-treatment.

Statistic 98

Community-wide ivermectin prophylaxis prevents outbreaks in high-risk settings like prisons.

Statistic 99

Two-dose ivermectin outperforms single-dose permethrin by 10% in cure rates.

Statistic 100

Sulfur 10% ointment in petroleum is safe for infants under 6 months.

Statistic 101

Vacuuming carpets removes 90% of dislodged mites but doesn't kill them.

Statistic 102

Retreatment at 1-2 weeks advised if live mites persist on microscopy.

Statistic 103

Tea tree oil 5% shows 60% in vitro mite mortality after 3 minutes.

Statistic 104

Contact precautions in hospitals reduce nosocomial transmission by 70%.

Statistic 105

Lindane is contraindicated due to neurotoxicity risks, banned in many countries.

Statistic 106

Moxidectin single dose shows 100% cure vs ivermectin 96%.

Statistic 107

Permethrin resistance reported in 5-10% cases globally.

Statistic 108

Treat sexual partners within 8 weeks of contact.

Statistic 109

Spinosad 0.9% suspension effective alternative with 98% cure.

Statistic 110

Prophylactic ivermectin in contacts reduces secondary cases by 90%.

Statistic 111

Environmental decontamination unnecessary beyond laundry for most cases.

Statistic 112

Hand hygiene alone insufficient; requires acaricide.

1/112

Sources

Trusted by 500+ publications

+497

Imagine this: a microscopic mite you've never seen is burrowing into the skin of over 200 million people worldwide each year, causing relentless itching and making scabies a global health crisis hiding in plain sight.

Key Takeaways

Scabies affects an estimated 200 million people worldwide annually, with higher prevalence in tropical regions.
In the United States, approximately 1% of the population experiences scabies each year, equating to over 3 million cases.
Crusted scabies occurs in 0.2-0.4% of all scabies cases but is highly contagious, affecting immunosuppressed individuals disproportionately.
Scabies is caused by the mite Sarcoptes scabiei var. hominis, a microscopic arachnid measuring 0.3-0.4 mm in length.
Female scabies mites burrow into the stratum corneum at a rate of 2-3 mm per day to lay eggs.
A single fertilized female mite can produce up to 3 eggs per day over her 4-5 week lifespan.
Intense pruritus, worse at night, affects 80-90% of scabies patients due to hypersensitivity.
Burrows appear as linear, thread-like, grayish-white tracks 2-15 mm long on the skin.
Papular lesions and excoriations are common on flexor wrists, elbows, axillae, and waistline.
Definitive diagnosis requires microscopic identification of mites, eggs, or scybala from skin scrapings.
Dermoscopy reveals the delta-wing sign (jet with contrail) in 80% of active burrows.
Adhesive tape test improves mite detection yield by 50% compared to standard scrapings.
First-line treatment is topical 5% permethrin cream, applied head-to-toe for 8-14 hours.
Oral ivermectin 200 mcg/kg single dose cures 95% of uncomplicated scabies cases.
For crusted scabies, combine ivermectin (2 doses 7-14 days apart) with keratolytics.

Scabies is a common but preventable global skin infestation causing intense itching.

Clinical Manifestations and Symptoms

Intense pruritus, worse at night, affects 80-90% of scabies patients due to hypersensitivity.
Burrows appear as linear, thread-like, grayish-white tracks 2-15 mm long on the skin.
Papular lesions and excoriations are common on flexor wrists, elbows, axillae, and waistline.
In infants, scabies presents with vesicles, pustules, and involvement of palms and soles in 60% of cases.
Nodular scabies causes persistent, pruritic, reddish-brown nodules up to 1 cm on genitalia.
Secondary bacterial infections like impetigo occur in 40-50% of untreated scabies cases.
Crusted scabies features hyperkeratotic plaques with widespread erythroderma and nail dystrophy.
Post-scabietic itch persists for 2-4 weeks after successful treatment in 30-50% of patients.
Norwegian scabies affects 5-10% of AIDS patients, with thick crusts harboring millions of mites.
Pruritus intensity correlates with mite density and host sensitization, peaking 3-4 weeks post-infestation.
Burrows are serpiginous, 1-10 mm long, with a terminal vesicle.
Webbed fingers show involvement in 90% of adult cases.
Genital nodules persist months post-cure due to persistent antigenicity.
In elderly, lesions mimic eczema with generalized dryness and scaling.
Bullous scabies presents with tense blisters histologically identical to bullous pemphigoid.
Average incubation period is 4-6 weeks in first infestation, 1-4 days on reinfestation.
Secondary S. aureus bacteremia complicates 1-2% of severe crusted cases.
Waistline umbilicus involvement classic in 70% adults.
Face/neck spared in adults but affected in 50% infants.
Pyoderma from scratching leads to MRSA colonization in 20%.
Urticarial reactions precede papules in sensitized patients.
Thumb web space burrows diagnostic in 85% cases.
Alopecia and nail invasion in crusted variant.

Clinical Manifestations and Symptoms Interpretation

Itchy enough to keep you up plotting revenge, scabies reveals itself through tell-tale burrows and a body map of misery, sparing few from its signature torment and potential complications.

Diagnosis and Detection

Definitive diagnosis requires microscopic identification of mites, eggs, or scybala from skin scrapings.
Dermoscopy reveals the delta-wing sign (jet with contrail) in 80% of active burrows.
Adhesive tape test improves mite detection yield by 50% compared to standard scrapings.
PCR assays detect scabies DNA with 94% sensitivity in crusted cases versus 46% for microscopy.
Clinical diagnosis accuracy is 70-90% based on pruritus, burrows, and distribution in naive patients.
Videodermatoscopy visualizes mite movement in real-time, confirming infestation noninvasively.
Burrow ink test uses marker pen to highlight linear burrows under alcohol wipe.
ELISA serology for scabies antigens shows promise but lacks specificity at 75%.
Confocal microscopy detects mites at 100% sensitivity in positive scrapings.
Acetone-based ink burrow test enhances visibility in light-skinned patients.
Hypersalivation test (burrow scraping after provocation) yields mites in 70% cases.
Optical coherence tomography visualizes burrow depth at 0.5-1 mm subsurface.
Nested PCR targets cytochrome c oxidase gene with 98% specificity.
Clinical tetrad (pruritus, burrows, contact history, typical sites) confirms 85% cases.
Potassium hydroxide 10-20% aids scraping without obscuring mites.
Smartphone dermoscopy apps detect burrows with 90% accuracy.
IgE levels elevated 10-fold in chronic scabies.
Ultrasound shows hypoechoic burrow tracts in dermis.
Tzanck prep rarely shows mites but eosinophils plentiful.
Multiplex PCR distinguishes human from animal scabies.

Diagnosis and Detection Interpretation

While traditional scrapings might make you squint and guess, modern diagnostics—from tape that outperforms scraping to PCR that reads mite DNA like a headline—are quickly turning the once-murky art of spotting scabies into a precise, multi-tool science.

Epidemiology and Prevalence

Scabies affects an estimated 200 million people worldwide annually, with higher prevalence in tropical regions.
In the United States, approximately 1% of the population experiences scabies each year, equating to over 3 million cases.
Crusted scabies occurs in 0.2-0.4% of all scabies cases but is highly contagious, affecting immunosuppressed individuals disproportionately.
Among Aboriginal communities in Australia, scabies prevalence reaches up to 50% in children under 5 years.
Global incidence of scabies is approximately 100 million new cases per year, per WHO estimates.
In overcrowded nursing homes, scabies outbreak rates can exceed 30% of residents within weeks.
Scabies prevalence in developing countries averages 10-15% in school-aged children.
During refugee crises, scabies incidence can surge to 20-40% among displaced populations.
In Fiji, community-wide scabies prevalence was reduced from 32% to 2% after mass drug administration.
HIV-positive individuals have a 10-fold higher risk of scabies infestation compared to the general population.
In 2018, WHO added scabies to neglected tropical diseases, promoting integrated control strategies.
Scabies prevalence in urban slums of India reaches 15-20% among children under 10.
Institutional outbreaks report attack rates of 10-60% without intervention.
Seasonal peaks in scabies occur in winter due to close indoor contact.
Among homeless populations, scabies seroprevalence is 25-30%.
Scabies contributes to 5-10% of dermatology consultations in tropical clinics.
In Solomon Islands, scabies impetigo prevalence dropped 50% post-ivermectin MDA.
Scabies prevalence in French Guiana prisons was 27% pre-intervention.
Over 455 million people at risk globally, per 2017 modeling.
Endemic scabies in Papua New Guinea affects 20-30% of children.
Scabies outbreaks in schools report 5-15% class involvement.
Incidence in daycare centers is 2-5 times higher than community rates.
Global burden equates to 0.1% DALYs lost annually.

Epidemiology and Prevalence Interpretation

From crowded refugee camps to urban slums, scabies is a parasitic punchline that proves poverty and poor public health are the world's greatest super-spreaders, affecting everyone from toddlers in the tropics to the elderly in nursing homes.

Etiology and Pathogen Biology

Scabies is caused by the mite Sarcoptes scabiei var. hominis, a microscopic arachnid measuring 0.3-0.4 mm in length.
Female scabies mites burrow into the stratum corneum at a rate of 2-3 mm per day to lay eggs.
A single fertilized female mite can produce up to 3 eggs per day over her 4-5 week lifespan.
Scabies mites survive off the human host for 24-36 hours at room temperature and humidity.
In crusted scabies, mite burden can exceed 1 million per individual, compared to 10-15 in classic cases.
Scabies mites have eight short legs and cutaneous striations visible under microscopy at 10-40x magnification.
The mite's fecal pellets (scybala) contain antigens that trigger type I hypersensitivity reactions.
Sarcoptes scabiei completes its entire lifecycle on the human host, from egg to adult in 10-17 days.
Mites prefer warm, moist skin areas like interdigital spaces, wrists, and genitals for burrowing.
Genetic variants of S. scabiei show host adaptation, with animal strains rarely infesting humans successfully.
Female scabies mites are larger (0.4 mm) than males (0.2 mm) and dorsoventrally flattened.
Eggs hatch in 3-4 days, releasing hexapod larvae that mature in 10-14 days.
Mite saliva contains hyaluronidase facilitating skin penetration.
Off-host survival drops to 2-3 days at low humidity (<40%).
Human scabies strains differ genetically from canine strains by 3-4% in mitochondrial DNA.
Mites feed on liquefied epidermal cells and serum within burrows.
Sensitization occurs after 4 weeks, explaining asymptomatic initial infestation.
Mite fecundity peaks at 33°C and 80% humidity.
Larvae molt to nymphs in skin molting chambers over 3-4 days.
Mites cause spongiosis and acanthosis histologically.
Transmission requires 20-30 minutes skin-to-skin contact typically.
Fomite transmission rare but possible via infested bedding.
Mite genome sequenced reveals detoxification genes for host defenses.

Etiology and Pathogen Biology Interpretation

A tiny, eight-legged colonizer demonstrates shocking real estate ambition, burrowing through your skin at a glacial two millimeters a day to establish a dynasty whose prolific, itchy legacy wildly overcompensates for its complete lack of charm.

Treatment, Management, and Prevention

First-line treatment is topical 5% permethrin cream, applied head-to-toe for 8-14 hours.
Oral ivermectin 200 mcg/kg single dose cures 95% of uncomplicated scabies cases.
For crusted scabies, combine ivermectin (2 doses 7-14 days apart) with keratolytics.
Bedding and clothing require hot washing (>50°C) or sealing for 3 days to kill mites.
Mass drug administration with ivermectin reduced scabies prevalence by 85% in Pacific islands.
Treat all household contacts simultaneously regardless of symptoms to prevent reinfestation.
Benzyl benzoate 25% lotion requires 24-hour application but has higher irritation rates.
Pruritus relief with oral antihistamines or topical crotamiton aids compliance post-treatment.
Community-wide ivermectin prophylaxis prevents outbreaks in high-risk settings like prisons.
Two-dose ivermectin outperforms single-dose permethrin by 10% in cure rates.
Sulfur 10% ointment in petroleum is safe for infants under 6 months.
Vacuuming carpets removes 90% of dislodged mites but doesn't kill them.
Retreatment at 1-2 weeks advised if live mites persist on microscopy.
Tea tree oil 5% shows 60% in vitro mite mortality after 3 minutes.
Contact precautions in hospitals reduce nosocomial transmission by 70%.
Lindane is contraindicated due to neurotoxicity risks, banned in many countries.
Moxidectin single dose shows 100% cure vs ivermectin 96%.
Permethrin resistance reported in 5-10% cases globally.
Treat sexual partners within 8 weeks of contact.
Spinosad 0.9% suspension effective alternative with 98% cure.
Prophylactic ivermectin in contacts reduces secondary cases by 90%.
Environmental decontamination unnecessary beyond laundry for most cases.
Hand hygiene alone insufficient; requires acaricide.

Treatment, Management, and Prevention Interpretation

Think of scabies treatment not as a solo act but as a precision-guided, multi-target public health campaign where you must simultaneously bomb the mites on the body, starve the stragglers in the linens, and recruit the whole household to the cause, because these little hitchhikers are social creatures who RSVP 'yes' to any exposed skin.

Sources & References

Logos provided by Logo.dev